USA: Aspiration Pneumonia Risk Increased for GLP-1 RA Users Undergoing Endoscopy

Patients using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) undergoing endoscopic procedures have an increased risk for aspiration pneumonia, according to a study published online March 27 in Gastroenterology.

Yee Hui Yeo, M.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues examined the incidence and risk for aspiration pneumonia associated with endoscopic procedures among patients who received GLP-1 RAs in a population-based, retrospective cohort study. Data were included from 963,184 individuals who underwent endoscopy: 95.1 and 4.9 percent were GLP-1 RA nonusers and users, respectively.

Source: Advances and More licensed by HealthDay